Abstract
Araujia sericifera is a native perennial, climbing laticiferous shrub from South America that is currently
naturalized in many other countries. Previous data describe promising properties for
A. sericifera, but no systematic study of its bioactive compounds and possible medicinal applications
has been conducted to date. In the present study, aerial parts of A. sericifera (leaves, stems, and fruits) were explored by combining GC-MS and NMR spectroscopy
analysis for both nonpolar (hexane) and polar (methanol) extracts. The hexanic extracts
contained high amounts of pentacyclic triterpenes including two new metabolites, 3-tigloyl
germanicol (18) and 3-tigloyl lupeol (19). The methanolic extracts revealed the presence of luteolin-7-glucoside (24), trigonelline (22), and conduritol F (23) as the main constituents. A multivariate study of a meaningful number of extracts
allowed us to determine the distribution of compounds inside the plant. A cytotoxic
evaluation in vitro showed that both leaf and fruit hexanic extracts presented a moderate activity against
human breast carcinoma cell lines (MDA-MB-453 and MCF-7) and human colon carcinoma
cell line (HCT-116) by the MTS [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium]
assay.
Key words
Araujia sericifera
- Asclepiadaceae - metabolite profile - cancer cell lines - GC-MS - NMR spectroscopy